-
Unconfirmed coronavirus treatment
-
Major indices keep surging
-
Oil prices up almost 4%
-
Astonishing ADP data from the US
Another day brings us key news on coronavirus, which is crucial for the future global economy outlook. As of Wednesday, China’s officials confirmed more than 24,000 cases, resulting in almost 500 deaths. This time however, we might as well be a little bit optimistic as China’s TV reports about a possible drug that is about to treat people with the coronavirus.
Multiple reports of a possible treatment are regarded as a possible breakthrough by the markets. Major indices in the US and Europe are surging, the growth pace is not as impressive as yesterday, though.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile app
Worth mentioning is certainly the oil price. Both Brent and WTI are up almost 4%. An astonishing surge may result from a dose of optimism regarding coronavirus - a long-term demand in China might not collapse entirely. Moreover, OPEC allies are reportedly considering further output cuts to counter a possible drop in global oil demand.
As far as economic data is concerned, markets were surprised by terrific employment figures from the US. According to ADP, private payrolls rose by 291,000 in January, which is the highest increase since May 2015 and well above the 150,000 estimate. The figure may be viewed as a key indicator for the US economy and such astonishing growth helps the US dollar to gain against the euro. In addition to that, the ISM Non-Manufacturing Index was released. The latest reading showed a solid 55.5 points, beating 55.1 expectations. The latter also helps maintain a strong position of the US dollar.
Oil prices are up almost 4% today. Possible coronavirus treatment and alleged OPEC news may have had an impact. Source: xStation5
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
